8-K
filed January 8, 2024, 6:59 PM ET
ticker EXEL
CIK 0000939767
other material
confidence medium
sentiment negative
materiality 0.75
EXELIXIS, INC. (EXEL): restructuring charge — Exelixis cuts 13% of workforce, authorizes $450M share repurchase, adds two directors
EXELIXIS, INC.
- Restructuring plan: workforce reduction of ~175 employees (13% of total headcount); total charges estimated at ~$25M, recognized in Q1 2024.
- Board authorized $450M share repurchase program for 2024; company also issued preliminary FY2023 results and FY2024 guidance (details in press release).
- Appointed Mary C. Beckerle and S. Gail Eckhardt to the Board, effective immediately; Alan M. Garber not standing for re-election.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
EXELIXIS, INC. updated its fiscal year ended December 29, 2023 guidance (initiated).
- Period
- fiscal year ended December 29, 2023
- Guidance
- initiated
- Result
- preliminary results
Exact text from the filing
On January 7, 2024, Exelixis, Inc. (Exelixis or the Company) issued a press release announcing its preliminary unaudited financial results for the fiscal year ended December 29, 2023, providing financial guidance for the fiscal year ending January 3, 2025, and delivered an update on its business.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
S. Gail Eckhardt was appointed as Director at EXELIXIS, INC..
- Action
- appointed
- Role
- Director
Exact text from the filing
the Board increased the size of the Board to 13 members and appointed Mary C. Beckerle, Ph.D. and S. Gail Eckhardt, M.D. to the Board to fill the newly created vacancies, effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Mary C. Beckerle was appointed as Director at EXELIXIS, INC..
- Action
- appointed
- Role
- Director
Exact text from the filing
the Board increased the size of the Board to 13 members and appointed Mary C. Beckerle, Ph.D. and S. Gail Eckhardt, M.D. to the Board to fill the newly created vacancies, effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Alan M. Garber departed as Director at EXELIXIS, INC..
- Action
- decided not to stand for re-election
- Role
- Director
Exact text from the filing
Alan M. Garber, M.D., Ph.D., informed the Company that he has decided not to stand for re-election to the Board when his term expires at the 2024 annual meeting of stockholders.
View on SEC.gov
Restructurings & Charges
SEC 8-K Item 2.05/2.06
confidence 0.9
EXELIXIS, INC. announced a restructuring with charges of $25 million (approximately 175 employees or 13% of our total headcount at the end of 2023).
- Type
- restructuring
- Charge
- $25 million
- Headcount
- approximately 175 employees or 13% of our total headcount at the end of 2023
Exact text from the filing
On January 5, 2024, the Company’s Board of Directors (the Board) authorized a restructuring plan (the Plan) to reduce its workforce and rebalance the Company’s cost structure in alignment with its strategic priorities, including reducing real estate commitments and costs and terminating certain licensing partnerships. In connection with the Plan, the Company currently estimates that it will incur aggregate charges of approximately $25 million, $13.5 million of which relate to the workforce reduction. The Company expects these costs will be substantially recognized during the first quarter of 2024. The Plan will result in a workforce reduction of approximately 175 employees or 13% of our total headcount at the end of 2023.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.